I've just summarised the Feb 25 Vertex investor conference, includes info about Kalydeco, VX809, VX661 and second generation correctors:
http://sixtyfiverosesblog.wordpress.com/2014/02/27/february-2014-vertex-update/
Also, last week it was announced that Kalydeco received FDA approval for eight gating mutations: G178R, S549N, S549R, G551S, G1244E, S1251N, S1255P and G1349D.
http://investors.vrtx.com/releasedetail.cfm?ReleaseID=827435
http://sixtyfiverosesblog.wordpress.com/2014/02/27/february-2014-vertex-update/
Also, last week it was announced that Kalydeco received FDA approval for eight gating mutations: G178R, S549N, S549R, G551S, G1244E, S1251N, S1255P and G1349D.
http://investors.vrtx.com/releasedetail.cfm?ReleaseID=827435